ACCLAIM BIOTECHNOLOGY

Basic Information

ACCLAIM BIOTECHNOLOGY
3520 PLUMB ST
HOUSTON, TX, 77005 0292

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Targeted Prodrug Therapy of Liver Cancers

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Hepatocellular carcinoma (HCC) and colorectal cancer (CRC) are among the most common and deadly malignancy worldwide. CRC is the second leading cause of cancer-re ...

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government